However, this is in contrast to tumor samples from glioblastomas, where YKL-40 acted as a biomarker of genetic and histological subtypes, radiation therapeutic response and prognosis [11,12,14,29,30]. The gene discussed is CHI3L1; the disease is glioblastoma.